Cleared Traditional

K072607 - LYOPHILIZED EARLY CLEAVAGE MEDIUM (ECM) KIT

K072607 is an FDA 510(k) clearance for LYOPHILIZED EARLY CLEAVAGE MEDIUM (ECM) KIT, manufactured by Irvine Scientific Sales Co., Inc.. The device is a Class 2 Obstetrics & Gynecology device with product code MQL cleared through the Traditional 510(k) pathway after a 130-day FDA review.

K072607 · Irvine Scientific Sales Co., Inc. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2008
Decision
130d
Days
Class 2
Risk

K072607 is an FDA 510(k) clearance for the LYOPHILIZED EARLY CLEAVAGE MEDIUM (ECM) KIT. Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by Irvine Scientific Sales Co., Inc. (Santa Ana, US). The FDA issued a Cleared decision on January 25, 2008 after a review of 130 days - within the typical 510(k) review window.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Irvine Scientific Sales Co., Inc. devices

FDA 510(k) Submission Details - K072607

510(k) Number K072607 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 17, 2007
Decision Date January 25, 2008
Days to Decision 130 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
30d faster than avg
Panel avg: 160d · This submission: 130d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQL Device Classification - Class 2, Special Controls

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQL Media, Reproductive

All 167
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K072607.
G-IVF G5 SERIES
K081116 · Vitrolife Sweden AB · Sep 2008
SINGLE STEP MEDIUM
K072609 · Irvine Scientific Sales Co., Inc. · Feb 2008
LYOPHILIZED MULTIBLAST MEDIUM KIT
K072608 · Irvine Scientific Sales Co., Inc. · Jan 2008
LG SPERM FREEZING
K070689 · Intl., Inc. · Jul 2007
EMBRYOASSIST
K061309 · Medicult A/S · Feb 2007
SPERMSLOW
K061145 · Medicult A/S · Oct 2006